The previous studies on the intestinal bacterial metabolites of ginsenosides suggested that the pathway of ginsenoside metabolism by intestinal bacteria begins with the attack to sugar moieties at the position C-20 and ends with the attack to sugar moieties at the position C-3, and one of the major terminal products of this pathway is C-K. 6, 11) However, we found a new kind of snailase with special properties, which may hydrolyze sugar moieties at the position C-3 of ginsenosides firstly. Thus, in order to clarify additional active components of Ginseng, we studied on other metabolites of ginsenosides, using the enzyme. As the results, a novel metabolite was isolated and characterized. In this paper, we report the preparation, structural elucidation and activity in reversing the doxocubicin, or adriamycin (ADM), resistance of the metabolite from ginsenoside Rb 3 with glycosidase hydrolysis.
Results and Discussion
The mixture of G-Rb 1 , G-Rb 2 , G-Rb 3 , G-Rc and G-Rd, derived from the methanol extract of Panax notoginseng leaves, was digested with crude snailase to afford C-K and a less polar novel metabolite, named as compound Mx (C-Mx).
From the IR spectrum, C-Mx was assumed to contain a double bond (1640 cm
Ϫ1
) and hydroxy group (3400 cm Ϫ1 Table 2) with those of protopanaxadiol, protopanaxatriol and other ginsenosides suggested that C-Mx is a diol-type of ginsenoside. [12] [13] [14] In the and G-Rb 3 . The differences in NMR spectra among them are derived from the differences in their glycosyl moieties. C-Mx was tested for its cytotoxicity against the human tumor cell line MCF-7 and its subline resistant to doxocubicin (ADM) MCF-7/ADM, and its effects on the sensitivity to ADM of MCF-7/ADM cells (Table 3) . MCF-7/ADM cells were highly resistant to ADM when compared with MCF-7 cells, and the IC 50 value of ADM in MCF-7/ADM cells was 120 fold that in MCF-7 cells. Both MCF-7 and MCF-7/ADM cells were sensitive to the toxicity of C-Mx to the same extent although a slight difference was observed. When a marginally toxic quantity of C-Mx was added to MCF-7/ADM cell growth medium, the 37.5 mM/ml IC 50 of ADM was shifted to 7.61 mM/ml, and the MDR (multidrug resistance) ratio of C-Mx was 4.9 according to equation (1) .
C-K, C-Y and G-Mc are the metabolites of G-Rb 1 , G-Rb 2 and G-Rc produced by human intestinal bacteria.
10) C-Y and G-Mc differ from C-K in the presence of an additional sugar moiety, which is a-L-arabinopyranosyl for C-Y but a-L-arabinofuranosyl for G-Mc (Table 1) . It has been reported that these metabolites have moderate cytotoxicity to 7, 8) and partial reversal of multidrug resistance of human tumor cells. 9, 10) This work disclosed a dammarane glycoside, C-Mx, derived from G-Rb 3 , which is abundant in Panax notoginseng leaves, and the analogue of C-K has the similar bioactivity.
Experimental
Melting points were determined on a WRS-1B digital melting point apparatus (Shanghai Precision Scientific Instrument Co. Ltd., China); The 1 Hand 13 C-NMR spectra were measured with a Varian Inova 300 Spectrometer (Talo Alto, CA, U.S.A.) and chemical shifts are expressed in d from TMS as an internal standard; mass spectra were taken on a EIMS spectrometer (TSQ-7000, Finnigan); and IR spectra were recorded with a TENSOR 27 FT-IR spectrometer (Bruker, Germany).
The dry powder of Panax notoginseng leaves (1 kg, from Yunnan, China, deposited at a dry and adumbral place at room temperature) was extracted with methanol (3 lϫ3) at room temperature. The methanol extract (130 g) was successively purified on a macro-reticular resin (Amberlite XAD7, Sigma) column and then an anion-exchange resin (Amberlite IRA-900, Sigma) column to give 70% EtOH eluates that afforded the total saponins (70 g) after drying. The total saponins were dissolved in 10% NaOH aqueous solution (1 l) and extracted with water-saturated 1-butanol (300 mlϫ5). The aqueous layer was neutralized with 1 mol HCl solution and extracted with water-saturated 1-butanol (200 mlϫ3). The 1-butanol layer was taken and evaporated under vacuum to yield a diol-type of ginsenosides (45 g).
The diol-type of ginsenosides (5 g) was hydrolyzed with crude snailase (3 g, from Sigma) for 24 h at 40°C in 300 ml of 0.01 mol phosphate-citrate buffer (pH 4.5) containing 10% EtOH. The precipitate thus formed was dissolved in water (30 ml) and the solution thus obtained was extracted with water-saturated 1-butanol (20 mlϫ3). The 1-butanol layer was evaporated under vacuum to yield the hydrolyzate (3 g). The hydrolyzate (3 g) was applied to a silica gel flash column (100 mmϫ25 mm i.d. (inner diameter)) eluted with EtOAc-1-BuOH-H 2 O (10 : 1 : 1→5 : 1 : 1, upper layer) to afford C-K and a subfraction. The subfraction was evaporated to give the dammarane glycoside C-Mx (600 g). Table 2 .
The human breast cancer cell line MCF-7, and its resistant subline MCF-7/ADM were used as the target cells in the cytotoxicity assay. Exponentially growing cells were prepared and maintained at 37°C in RPMI 1640 containing 10% fetal bovine serum, 0.5% DMSO and gentamycin sulfate (80 m/ml). C-Mx or ADM was first dissolved in PBS containing 0.5% DMSO at a suitable concentration and further diluted with the growth medium. For drug exposure experiments, tumor cells (1ϫ10 5 ) were inoculated into 96-well plates containing serial 1 : 2 dilutions of C-Mx or ADM in the presence or absence of C-Mx at a marginally toxic concentration (6 mM, growth inhibition less than 10%) in a final volume of 200 ml of growth medium and incubated at 37°C in a humidified atmosphere of 5% CO 2 air for 44 h. After incubating, 10 ml of MTT solution (5 mg/ml) was added to each well and incubated for further 4 h. At the end of the incubation, the growth medium was removed and replaced with 100 ml of DMSO (at room temperature). After agitating on a vortex for 5 min, the absorbance was determined at 550 nm and 620 nm as reference on a Bio-Rad (model 550) microplate reader to calculate 50% inhibition concentration (IC 50 ). The MDR ratio was obtained using the following equation:
MDR ratioϭIC 50 ADM /(IC 50 ADMϩC-Mx )
DMSO, ADM and MTT were purchased from Sigma Chemical Co. Glc O-Glc (St. Louis, MO, U.S.A.). The results are summarized in Table 3 . 
